We are live on
!
Find out more
KFS
Kurt F. Somerville Portfolio holdings
AUM
$379M
1-Year Est. Return
19.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.87%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$585M
AUM Growth
+$53.6M
(+10%)
Cap. Flow
+$7.15M
Cap. Flow
% of AUM
1.22%
Top 10 Holdings %
Top 10 Hldgs %
41.22%
Holding
102
New
6
Increased
31
Reduced
35
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ball Corp
BALL
|
+$2.9M |
| 2 |
Carrier Global
CARR
|
+$2.79M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$1.11M |
| 4 |
UnitedHealth
UNH
|
+$881K |
| 5 |
Aptiv
APTV
|
+$866K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$4.34M |
| 2 |
CVS Health
CVS
|
+$1.86M |
| 3 |
Advanced Micro Devices
AMD
|
+$1.32M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$539K |
| 5 |
NVIDIA
NVDA
|
+$494K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.87% |
| 2 | Healthcare | 21.23% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Financials | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amgen
AMGN
$210B
| $342K | 0.06% |
1,202
| – | – |
|
77
Pfizer
PFE
$145B
| $339K | 0.06% |
12,233
-1,558
| -11% | -$43.2K |
|
78
TotalEnergies
TTE
$190B
| $337K | 0.06% |
4,900
| – | – |
|
79
Illumina
ILMN
$30.4B
| $334K | 0.06% |
2,503
-1,707
| -41% | -$229K |
|
80
Bristol-Myers Squibb
BMY
$135B
| $326K | 0.06% |
6,007
-1,275
| -18% | -$65K |
|
81
Waste Management
WM
$90.1B
| $311K | 0.05% |
1,460
-160
| -10% | -$31.4K |
|
82
Texas Pacific Land
TPL
$27.5B
| $304K | 0.05% |
1,575
| – | – |
|
83
Gilead Sciences
GILD
$164B
| $279K | 0.05% |
3,805
| – | – |
|
84
Pinterest
PINS
$14.3B
| $273K | 0.05% |
7,870
| – | – |
|
85
Oracle
ORCL
$424B
| $269K | 0.05% |
2,143
-205
| -9% | -$23.5K |
|
86
NXP Semiconductors
NXPI
$59.6B
| $266K | 0.05% |
1,075
| – | – |
|
87
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $254K | 0.04% |
+486
| New | +$242K |
|
88
Meta Platforms (Facebook)
META
$1.5T
| $243K | 0.04% |
+500
| New | +$223K |
|
89
Dover
DOV
$28.3B
| $230K | 0.04% |
+1,300
| New | +$209K |
|
90
T. Rowe Price
TROW
$24.3B
| $219K | 0.04% |
+1,800
| New | +$201K |
|
91
Kimberly-Clark
KMB
$36.9B
| $213K | 0.04% |
1,650
| – | – |
|
92
Edwards Lifesciences
EW
$51.2B
| – | – |
-4,600
| Closed | -$351K |
|
93
Veralto
VLTO
$23.4B
| – | – |
-3,221
| Closed | -$265K |
|
Similar funds
NICM
CFG
EAM
MC
ACA
AFCM
DAL
AWA
Kurt F. Somerville's Q1 2024 Portfolio in Review
As of Q1 2024, Kurt F. Somerville held 102 positions worth $585M, up 10% from $531M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Kurt F. Somerville's Q1 2024 filing shows 6 new, 31 increased, 35 reduced and 3 closed positions. Its largest new stake was Ball Corp: 47,674 shares worth $3.21M. The largest sale was Novartis, an estimated $4.34M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Kurt F. Somerville's largest Q1 2024 buy was Ball Corp: 47,674 shares worth $3.21M.
- Kurt F. Somerville added most to Vertex Pharmaceuticals in Q1 2024, an estimated $1.11M increase.
- Kurt F. Somerville's biggest Q1 2024 reduction was Novartis, cutting an estimated $4.34M.
- Kurt F. Somerville fully exited Edwards Lifesciences in Q1 2024, selling an estimated $351K.
- Kurt F. Somerville's ten largest holdings make up 41% of its $585M portfolio in Q1 2024.
- Kurt F. Somerville opened 6 new positions and closed 3 in Q1 2024.
- Kurt F. Somerville's portfolio value rose 10% quarter-over-quarter to $585M.
Based on Kurt F. Somerville's 13F filing for Q1 2024, filed 14 May 2024.